12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Viaskin Peanut: Completed Phase IIb enrollment

DBV completed enrollment of 221 patients ages 6-55 years in the double-blind, placebo-controlled, international Phase IIb VIPES trial evaluating 50, 100 and 250 µg Viaskin...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >